The relationship between the estimated tumor growth speed and indices of bromodeoxyuridine (BrdU) incorporation and the proliferating cell nuclear antigen (PCNA) expression in superficial bladder cancer

Japanese Journal of Urology

Volumn 88, Issue 10, 1997, Pages 868-873

  Ota, Tomonori ^a   Akaza, Hideyuki ^a   Hattori, Kazunori ^b   Uchida, Katsunori ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Ibaraki Seinan Medical Center Hospital   (Japan)

Author keywords

Bladder cancer; Bromodeoxyuridine (BrdU); Proliferating cell nuclear antigen (PCNA)

Indexed keywords

BROXURIDINE; CYCLINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; GROWTH RATE; HUMAN; HUMAN TISSUE; PROGNOSIS; RECURRENT CANCER; SUPERFICIAL CANCER; TUMOR GROWTH;

EID: 0030694705     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.88.868     Document Type: Article

References (22)

1. Williams, J.L., Hammonds, J.C. and Saunders, N.: T1 bladder tumors. Brit. J. Urol., 49, 663 -668, 1977.
2. Ploton, D., Menager, M., Jeannesson, P., Himber, G., Pigeon, F. and Adnet, J.J.: Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer regions at the optical level. Histochem. J., 18, 5-14, 1986.
3. Limas, C., Bigler, A., Bair, R., Bernhart, P. and Reddy, P.: Proliferative activity of urothelial neoplasms: Comparison of BrdU incorporation. Ki67 expression, and nucleolar organizer regions. J. Clin. Pathol., 46, 159-165, 1993.
4. Robbins, B.A., Vega, D , Ogata, K., Tan, E.M. and Nakamura, R.M.: Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch. Pathol. Lab Med., 111, 841-845, 1987.
5. Lipponen, P.K. and Eskelinen, M.J.: Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value. Br. J. Cancer, 66, 171 -176, 1992.
6. Hattori, K., Uchida, K., Akaza, H., Koiso, K., Nemoto, R. and Harada, M.: Proliferating cell nuclear antigen cyclin in human transitional cell carcinoma. Br. J. Urol., 75, 162-166, 1995.
7. Fontana, D., Bellina, M., Gubetta, L., Fasolis, G., Rolle, L., Scoffone, C., Porpiglia, F., Colombo, M., Tarabuzzi, R. and Leonardo, E.: Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma. J. Urol., 148, 1149-1151, 1992.
8. Barlogie, B., Raber, M.N., Schumann, J., Johnson, T.S., Drewinko, B., Swartzendruber, D.E , Göhde, W., Andreeff, M. and Freireich, E.J.: Flow cytometry in clinical cancer research. Cancer Res., 43, 3982-3997, 1983.
9. Williams, N.N. and Daly, J.N.: Flow cytometry and prognostic implications in patients with solid tumors. Surg. Gynecol. Obstet., 171, 257-266, 1990.
10. Clemo, F.A.S., DeNicola, D.B., Carlton, W.W., Morrison, W.B. and Walker, E.: Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders. Vet. Pathol., 31, 207-215, 1994.
11. Skopelitou, A., Korkolopoulou, P., Papanicolaou, A., Christodoulou, P., Thomas-Tsagli, E. and Pavlakis, K.: Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Eur. Urol., 22, 235-240, 1992.
12. Murray, P.G., Boldy, D.A.R., Crocker, J. and Ayres, J.G.: Sequential demonstration of antigens and AgNORs in frozen and paraffin sections. J. Pathol., 159, 169-172, 1989.
13. Waldman, F M., Carroll, P.R., Cohen, M.B., Kerschrnann, R., Chew, K. and Mayall, B.H.: 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder. Mod. Pathol., 6, 20-24, 1993.
14. Akaza, H., Koiso, K., Kotake, T., Matsumura, Y., Isaka, S., Machida, T., Obata, K., Ohashi, Y., Ohe, H , Ohi, Y., Shimazaki, J., Tashiro, K., Ueda, T., Kagawa, S., Niijima, T. and The Japanese Urological Cancer Research Group for Adriamycin: Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: Experience of the Japanese Urological Cancer Research Group for Adriamycin. Cancer Chemother. Pharmacol., 30, 15-20, 1992.
15. Akaza, H.: BCG treatment of existing Ta, T1 tumors or carcinoma in situ of the bladder. Euro. Urol., 27, 9-12, 1995.
16. Akaza, H., Hinotsu, S., Aso, Y., Kakizoe, T. and Koiso, K : Bacillus Calmette-Guerin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder. Four-year results. The Bladder Cancer BCG Study Group. Cancer, 75, 552-559, 1995.